Revenio Group Oyj (HEL:REG1V)

Market Cap	374.07M -49.8%
Revenue (ttm)	111.05M +4.4%
Net Income	15.71M -17.7%
EPS	0.59 -17.7%
Shares Out	26.61M
PE Ratio	23.90
Forward PE	16.45
Dividend	0.44 (3.13%)
Ex-Dividend Date	n/a

Volume	40,196
Average Volume	94,062
Open	14.10
Previous Close	14.08
Day's Range	13.92 - 14.24
52-Week Range	13.30 - 29.45
Beta	0.85
RSI	36.68
Earnings Date	Apr 28, 2026

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used by vet...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 246
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: REG1V

Financial Performance

In 2025, Revenio Group Oyj's revenue was 109.85 million, an increase of 5.80% compared to the previous year's 103.82 million. Earnings were 17.41 million, a decrease of -5.87%.